ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,594.63
      (
      0.59%
      )
      US Tech 100
      15,629.20
      (
      0.49%
      )
      Dow Jones
      36,245.50
      (
      0.82%
      )
      Brent Oil
      79.125
      (
      0.0%
      )
      Bitcoin
      39,510.27
      (
      0.08%
      )
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Outlook Therapeutics Inc (OTLK)

      7. Outlook Therapeutics Inc (OTLK) News

      OTLK

      Outlook Therapeutics (OTLK)

      Outlook Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:OTLK
      DateTimeSourceHeadlineSymbolCompany
      11/29/20234:01PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:OTLKOutlook Therapeutics Inc
      11/28/20235:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Outlook Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2024 - (NASDAQ: OTLK)NASDAQ:OTLKOutlook Therapeutics Inc
      11/27/20238:05AMGlobeNewswire Inc.Outlook Therapeutics® Announces Receipt of Type A Meeting Minutes and Reiterates Regulatory Path Forward for ONS-5010NASDAQ:OTLKOutlook Therapeutics Inc
      11/21/20235:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Outlook Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2024 - (NASDAQ: OTLK)NASDAQ:OTLKOutlook Therapeutics Inc
      11/14/20238:05AMGlobeNewswire Inc.Outlook Therapeutics® Adds Global Commercial Expertise with Appointment of Jedd Comiskey as Senior VP - Head of EuropeNASDAQ:OTLKOutlook Therapeutics Inc
      11/14/20235:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Outlook Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2024 - (NASDAQ: OTLK)NASDAQ:OTLKOutlook Therapeutics Inc
      11/02/20238:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OTLKOutlook Therapeutics Inc
      11/02/20238:05AMGlobeNewswire Inc.Outlook Therapeutics® Provides Update on Type A Meetings with FDANASDAQ:OTLKOutlook Therapeutics Inc
      11/01/20238:05AMGlobeNewswire Inc.Outlook Therapeutics® to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology (INI) ConferenceNASDAQ:OTLKOutlook Therapeutics Inc
      10/20/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OTLKOutlook Therapeutics Inc
      10/05/20235:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OTLKOutlook Therapeutics Inc
      10/05/20235:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OTLKOutlook Therapeutics Inc
      10/05/20235:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OTLKOutlook Therapeutics Inc
      10/05/20235:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OTLKOutlook Therapeutics Inc
      09/29/20238:05AMGlobeNewswire Inc.Outlook Therapeutics® Requests Type A Meeting With FDANASDAQ:OTLKOutlook Therapeutics Inc
      09/21/20238:05AMGlobeNewswire Inc.Outlook Therapeutics® to Present at the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:OTLKOutlook Therapeutics Inc
      09/05/20238:05AMGlobeNewswire Inc.Outlook Therapeutics® to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:OTLKOutlook Therapeutics Inc
      08/30/20236:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OTLKOutlook Therapeutics Inc
      08/30/20236:00AMGlobeNewswire Inc.Outlook Therapeutics® Provides Regulatory Update on FDA Review of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMDNASDAQ:OTLKOutlook Therapeutics Inc
      08/28/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OTLKOutlook Therapeutics Inc
      08/25/20234:31PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OTLKOutlook Therapeutics Inc
      08/14/20235:19PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OTLKOutlook Therapeutics Inc
      08/14/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OTLKOutlook Therapeutics Inc
      08/14/20238:05AMGlobeNewswire Inc.Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2023 and Reiterates Key Anticipated Near-Term MilestonesNASDAQ:OTLKOutlook Therapeutics Inc
      08/01/20238:45AMGlobeNewswire Inc.Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2023NASDAQ:OTLKOutlook Therapeutics Inc
      05/16/20237:10AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OTLKOutlook Therapeutics Inc
      05/16/20236:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTLKOutlook Therapeutics Inc
      05/15/20234:51PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTLKOutlook Therapeutics Inc
      05/15/20238:05AMGlobeNewswire Inc.Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2023 and Provides Corporate UpdateNASDAQ:OTLKOutlook Therapeutics Inc
      04/27/20238:05AMGlobeNewswire Inc.Outlook Therapeutics® to Present at the H.C. Wainwright BioConnect Investor ConferenceNASDAQ:OTLKOutlook Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:OTLK